SCHEDULE 13D/A: ModivCare Secures $50 Million in New Financing from Major Shareholder Group
Beneficial Ownership Update and Financing Agreement
ModivCare Inc. has entered into an agreement with its significant shareholder group, Coliseum Investors, to raise $30 million through the purchase of new second lien notes and exchange an additional $20 million of existing senior notes for the new notes, subject to shareholder approval.
Summary
- ModivCare Inc. has entered into a Purchase and Exchange Agreement with Coliseum Investors, which include Coliseum Capital Partners, L.P. and Blackwell Partners LLC Series A.
- Under the agreement, Coliseum Investors will purchase $30.0 million in aggregate principal amount of new second lien senior secured PIK toggle notes from ModivCare.
- Additionally, Coliseum Investors will exchange approximately $20.0 million in aggregate principal amount of their existing 5.000% Senior Notes due 2029 for an equivalent principal amount of the new second lien notes.
- The total aggregate principal amount of new second lien notes involved in these transactions is $50.0 million.
- The completion of these transactions is conditioned upon receiving approval from 66-2/3% of ModivCare's stockholders, as mandated by Section 203 of the Delaware General Corporation Law.
- The reporting persons, including Coliseum Capital Management, LLC, Adam Gray, and Christopher Shackelton, collectively beneficially own 2,982,751 shares, representing 20.9% of ModivCare's common stock.
Sentiment
Score: 6
Explanation: The transaction provides ModivCare with new capital and debt restructuring, which is generally positive for liquidity. However, the use of PIK toggle notes and the significant shareholder approval condition introduce some elements of caution, preventing a higher score.
Positives
- Secures $30.0 million in new capital for ModivCare Inc. through the purchase of second lien notes, enhancing liquidity.
- Refinances $20.0 million of existing 5.000% Senior Notes due 2029 into new second lien notes, potentially optimizing the debt structure.
- Demonstrates continued financial support and commitment from a significant shareholder group (Coliseum Investors), which holds 20.9% of the common stock.
Negatives
- The new notes are 'PIK toggle notes,' meaning interest can be paid in kind (additional notes) rather than cash, which could increase the principal debt burden if cash interest is not paid.
- The transaction is subject to a high shareholder approval threshold of 66-2/3%, introducing a significant conditionality risk.
- Issuance of second lien notes implies a junior position to existing senior debt, which might reflect a higher risk profile or increased cost of capital for the company.
Risks
- The Coliseum Transactions are conditioned upon the receipt of approval from 66-2/3% of the Issuer's stockholders pursuant to Section 203 of the Delaware General Corporation Law, meaning the financing may not close if this approval is not obtained.
- The nature of 'PIK toggle notes' could lead to an increase in the principal amount of debt if interest is paid in kind rather than cash, potentially increasing future debt obligations.
Future Outlook
The completion of the financing is contingent on obtaining 66-2/3% stockholder approval, which will determine the finalization of the capital infusion and debt restructuring.
Industry Context
This financing transaction by ModivCare Inc., a healthcare services company, reflects a common strategy for companies to manage their debt profiles and secure capital from existing large shareholders, especially in sectors that may require ongoing investment or face fluctuating market conditions. The use of PIK toggle notes can be a flexible financing tool, though it may also signal a need for cash flow management.
Related Party Transactions
- The transaction involves Coliseum Investors, a significant shareholder group (beneficially owning 20.9% of common stock), entering into a financing agreement with the Issuer, which constitutes a related party transaction.
Stakeholder Impact
- Shareholders: Will need to vote on the transaction, and the issuance of new notes could impact the company's capital structure and future earnings (due to interest payments). The transaction involves a major shareholder group, potentially influencing governance.
- Creditors: The new second lien notes will rank junior to existing senior debt, potentially affecting the recovery prospects of senior creditors in a default scenario.
Next Steps
- ModivCare Inc. must seek and obtain approval from 66-2/3% of its stockholders for the Coliseum Transactions.
- Closing of the Purchase and Exchange Agreement will occur upon satisfaction of all conditions, including stockholder approval.
Key Dates
| Date | Description |
|---|---|
| 2012-07-30 | Initial Schedule 13D filing date. |
| 2024-10-01 | Date from which accrued and unpaid interest on Second Lien Notes is calculated. |
| 2025-01-09 | Date of the Purchase and Exchange Agreement between ModivCare Inc. and Coliseum Investors. |
| 2025-01-10 | Date of filing of this Amendment No. 24 to Schedule 13D. |
Recommendation
holdKeywords
ModivCare Inc., SEC Filing, Schedule 13D, Coliseum Capital, Second Lien Notes, PIK Toggle Notes, Debt Financing, Shareholder Approval, Corporate Finance, Beneficial Ownership, Senior Notes, Capital Raise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.